title: [Diabetes in patients with malignant tumors].
abstract: Disturbances of the carbohydrate metabolism are fairly common is patients with malignancy. On the other hand, diabetes appears to have an effect on the development and progression of various tumors. Malignant diseases and the therapies used in their treatment often have an impact on carbohydrate metabolism, while diabetes may hinder specific oncotherapy or influence oncological therapeutic decisions. Several complications of malignant diseases and some of the medications used in their treatment, such as steroids or parenteral nutrition, may raise blood glucose levels. The various obstacles of oral nutrition frequently seen in patients with malignancy can lead to hypoglycaemia in patients with diabetes. Our article endeavours to review the pathophysiological and clinical connection between diabetes and malignant diseases and the use of insulin, oral antidiabetic drugs and diet in patients with malignant disease.
authors.affiliation: Általános Belgyógyászati Osztály, Szent Margit Kórház, Budapest, Hungary. lengyeldr@sztmargit.hu.
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Lengyel
authors.forename: Katalin
authors.initials: K
authors.lastname: Boér
authors.forename: Csaba
authors.initials: C
authors.lastname: Halászlaki
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Németh
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003920:Diabetes Mellitus / Q000097:blood / Q000178:diet therapy / Q000188:drug therapy / Q000378:metabolism*; D003927:Diet, Diabetic; D018450:Disease Progression; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000150:complications; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use*; D009369:Neoplasms / Q000097:blood / Q000150:complications / Q000378:metabolism*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin